All
RSSArticles
-
Study: Minorities Remain Underrepresented in Cancer Trials
A study of clinical trials involving cancer drugs over the past decade shows that the problem of studies enrolling too few racial and ethnic minorities has not improved, although the issue has been raised publicly for years.
-
Expert’s Inadequate Testimony Leads to Dismissal of Medical Malpractice Lawsuit
Although the facts of the case seem to indicate the physician acted within the accepted standard of care, the outcome may have been different had the patient selected a more experienced, better-suited expert and presented his claim with more specificity.
-
Birth Injury Litigation Results in $7.5 Million Settlement
This case raises a few lessons for physicians and care providers: whether the physicians failed to preserve and test either cord blood gases or the placenta, whether the physicians breached the applicable standard of care regarding the use of labor-inducing drugs and failing to monitor the fetus prior to delivery, and whether the physicians failed to ensure employees were aware of and complied with the hospital’s policies and procedures.
-
Sparsely Charted History and Physical Complicates Med/Mal Defense
Thorough charting on the history and physical of an ED patient can prove the standard of care was met. Still, the medical record often contains little more than a series of checkboxes.
-
Patient Safety Act Affords Protection for Adverse Event Investigations
The Patient Safety and Quality Improvement Act of 2005 affords substantial protections from discovery for information related to adverse events. Hospital leaders and clinicians often do not fully understand how to use these protections.
-
Lemborexant Tablets (Dayvigo)
Lemborexant should be prescribed to treat adults with insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
-
Opioid-Related Claims Show Need for Good Processes
The opioid crisis continues to create increased liability risks for healthcare providers, who must contend with more scrutiny over prescribing and management practices. A review of closed claims indicates hospitals and physicians can improve the way they follow guidelines and processes designed to reduce the risk.
-
Stable Coronary Disease and Atrial Fibrillation Patients Best Treated With Rivaroxaban Alone
Monotherapy with rivaroxaban was noninferior to combination therapy for the primary efficacy endpoint of composite of stroke, systemic embolism, myocardial infarction, unstable angina, or death from any cause.
-
What Is the Optimal Blood Pressure for Secondary Prevention of Stroke?
Investigators terminated a study early before they could draw any firm conclusions. Thus, there remains a lack of solid evidence to support a firm recommendation regarding optimal blood pressure management for secondary stroke prevention.
-
Dapagliflozin Treatment Improves Life Quality for Systolic Heart Failure Patients
Treatment with dapagliflozin for 12 weeks resulted in improved health status, either a reduction in NT-proBNP or improvement in quality of life measures, in systolic heart failure patients with or without type 2 diabetes mellitus.